You are here:
Areas of interest: Acute leukaemias, myelodysplastic syndromes, inherited predispositions to cancer
Dr Edward Chew is a clinical and diagnostic haematologist passionate about integrating molecular testing into routine clinical care. After obtaining his FRACP and FRCPA, he completed a PhD at The Walter and Eliza Hall Institute of Medical Research where he discovered a new cancer predisposition syndrome for acute myeloid leukaemia and bowel polyps. He next undertook a visiting scientist position with Professor Lucy Godley at The University of Chicago where he gained further experience in massively parallel sequencing. As an early career researcher, he has been awarded the Baikie Medal by the Haematology Society of Australia and New Zealand (HSANZ), the Victorian Fellowship and The VCCC Picchi Award.
Dr Chew is a national examiner for the Royal College of Pathologists of Australasia (RCPA, Haematology) and member of the RCPA Haematology Advisory Committee. He is a member of national and international societies, including as a Biocurator for the National Institutes of Health (NIH) ClinGen Myeloid Malignancy Variant Curation Expert Panel.